Skip to main content
$6.42 $0.20 (3.2%)

04:00 PM EST on 02/02/23

Durect Corp (NASDAQ:DRRX)

CAPS Rating: 1 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Current Price $6.42 Mkt Cap $141.7M
Open $6.23 P/E Ratio 0.00
Prev. Close $6.42 Div. (Yield) $0.00 (0.0%)
Daily Range $5.90 - $6.47 Volume 118,085
52-Wk Range $3.17 - $9.70 Avg. Daily Vol. 85,877

Caps

How do you think NASDAQ:DRRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

78 Outperform
21 Underperform
 

All-Star Players

12 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DRRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

hackwojr (96.60)
Submitted August 19, 2006

Durect has several products in phase II trials that will really be excellent for the treament of post operative pain. Striker, a company that would compete with Durect just purchased something like 18,000,000$ worth of shares of durect. They must… More

LifeScientist (29.25)
Submitted June 25, 2020

Pumping it, will be dumped. Rediculous thesis from pumpers about its candidate drug as support for Covid Remdesivir. Low short interest so narrow upside.

Recent Community Commentary

Read the most recent pitches from players about DRRX.

Recs

1
Member Avatar LifeScientist (29.25) Submitted: 6/25/2020 3:30:55 PM : Underperform Start Price: $2.62 NASDAQ:DRRX Score: -109.35

Pumping it, will be dumped. Rediculous thesis from pumpers about its candidate drug as support for Covid Remdesivir. Low short interest so narrow upside.

Recs

0
Member Avatar marsuculix (23.69) Submitted: 9/22/2016 9:36:11 AM : Outperform Start Price: $1.73 NASDAQ:DRRX Score: +180.32

FDA approval highly possible

Recs

0
Member Avatar xmpyre (< 20) Submitted: 5/1/2014 4:30:47 AM : Outperform Start Price: $1.31 NASDAQ:DRRX Score: +268.68

Held by the whim of regulation...future regulatory decisions will make or break this company

Leaderboard

Find the members with the highest scoring picks in DRRX.

Score Leader

huthuthike

huthuthike (26.56) Score: +478.21

The Score Leader is the player with the highest score across all their picks in DRRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
huthuthike 26.56 6/6/2013 Outperform 5Y $0.87 +636.15% +157.94% +478.21 0 Comment
HeikellP < 20 6/27/2012 Outperform 5Y $0.82 +682.93% +214.69% +468.24 0 Comment
Benl324 < 20 6/25/2012 Outperform 3M $0.83 +669.60% +217.64% +451.96 0 Comment
Biotechbillions < 20 7/16/2013 Outperform 5Y $1.09 +488.99% +147.66% +341.33 0 Comment
SmallCapSurfer2 67.48 10/13/2016 Outperform 3M $1.20 +435.00% +96.41% +338.59 0 Comment
xmpyre < 20 5/1/2014 Outperform 3Y $1.31 +390.08% +121.40% +268.68 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. CptEverGrande 48.87 11/2/2020 Outperform 1Y $1.71 +276.54% +26.73% +249.81 0 Comment
anticitradeshort 26.80 4/20/2009 Underperform NS $2.52 +154.76% +392.23% +237.46 0 Comment
stockanal45 35.01 2/26/2014 Outperform 5Y $1.40 +360.22% +124.84% +235.38 1 Comment
ValueHunter09 36.79 3/9/2015 Outperform 5Y $1.61 +298.76% +100.59% +198.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DRRX.